Incidence and Mortality and Epidemiology of Breast Cancer in the World

  • Ghoncheh, Mahshid (Department of Epidemiology & Biostatistics, School of Public Health, Hamadan University of Medical Sciences) ;
  • Pournamdar, Zahra (Pregnancy Health Research Center, Zahedan University of Health Sciences) ;
  • Salehiniya, Hamid (Zabol University of Medical Scince)
  • Published : 2016.06.01


Breast cancer is the most common malignancy in women around the world. Information on the incidence and mortality of breast cancer is essential for planning health measures. This study aimed to investigate the incidence and mortality of breast cancer in the world using age-specific incidence and mortality rates for the year 2012 acquired from the global cancer project (GLOBOCAN 2012) as well as data about incidence and mortality of the cancer based on national reports. It was estimated that 1,671,149 new cases of breast cancer were identified and 521,907 cases of deaths due to breast cancer occurred in the world in 2012. According to GLOBOCAN, it is the most common cancer in women, accounting for 25.1% of all cancers. Breast cancer incidence in developed countries is higher, while relative mortality is greatest in less developed countries. Education of women is suggested in all countries for early detection and treatment. Plans for the control and prevention of this cancer must be a high priority for health policy makers; also, it is necessary to increase awareness of risk factors and early detection in less developed countries.


  1. Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev,16, 2757-61.
  2. Bhikoo R, Srinivasa S, Yu TC, et al (2011). Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia. Cancers (Basel),3, 2382-401.
  3. Cecilio AP, Takakura ET, Jumes JJ, et al (2015). Breast cancer in Brazil: epidemiology and treatment challenges. Breast Cancer (Dove Med Press), 7, 43-9.
  4. Chlebowski RT (2013). Nutrition and physical activity influence on breast cancer incidence and outcome. Breast, 22, S30-7.
  5. Choi Y, Kim Y, Park SK, et al (2006). Age-period-cohort analysis of female breast cancer mortality in Korea. Breast Cancer, 13, 266-71.
  6. Clegg LX, Reichman ME, Miller BA, et al (2009). Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control, 20, 417-35.
  7. Downing A, Prakash K, Gilthorpe M, et al (2007). Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. Br J Cancer BJC, 96, 836-40.
  8. Ferlay JSI, Ervik M, Dikshit R, et al. (2013). Globocan 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer [Online]. Available: Available from:, accessed on 7/JUNE/2015.
  9. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, E359-E86.
  10. Fitzmaurice C, Dicker D, Pain A, et al (2015). The Global Burden of Cancer 2013. JAMA Oncol, 1, 505-27.
  11. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015). Incidence and Mortality of Breast Cancer and their Relationship to Development inAsia. Asian Pac J Cancer Prev,16, 6081-7.
  12. Harford JB, Edwards BK, Nandakumar A, et al (2009). Cancer control-planning and monitoring population-based systems. Tumori, 95, 568-78.
  13. Hoerger TJ, Ekwueme DU, Miller JW, et al (2011). estimated effects of the national breast and cervical cancer early detection program on breast cancer mortality. Am J Prev Med,40, 397-404.
  14. Munzone E (2014). Highlights from the ninth European breast cancer conference, glasgow, 19-21 march 2014. Ecancermedicalscience, 8, 426-32.
  15. Rahimzadeh M, Baghestani AR, Gohari MR, et al (2014). Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev,15, 4839-42.
  16. Razi S, Enayatrad M, Mohammadian-Hafshejani A, et al (2015a). The Epidemiology of Skin Cancer and its Trend in Iran. Int J Prev Med, 6, 64-9.
  17. Razi S, Rafiemanesh H, Ghoncheh M, et al (2015b). Changing Trends of Types of Skin Cancer in Iran. Asian Pac J Cancer Prev,16, 4955-8.
  18. Roshandel G, Boreiri M, Sadjadi A, et al (2014). A diversity of cancer incidence and mortality in West Asian populations. Ann Glob Health, 80, 346-57.
  19. Torre LA, Bray F, SiegelRL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108.
  20. Vahabi M, Lofters A, Kumar M, et al (2015). Breast cancer screening disparities among urban immigrants: a population-based study in Ontario, Canada. BMC Public Health, 15, 679.
  21. WHO, (2014). World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. [Online]. WHO. Available:
  22. WHO, (2015). Breast cancer: prevention and control [Online]. Available:].
  23. Yip CH, Buccimazza I, Hartman M, et al (2015). Improving outcomes in breast cancer for low and middle income countries. World J Surg, 39, 686-92.
  24. Youlden DR, Cramb SM, Yip CH, et al (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11, 101-15.
  25. Zahedi A, Rafiemanesh H, Enayatrad M, et al (2015). Incidence, trends and epidemiology of cancers in North West of Iran. Asian Pac J Cancer Prev, 16, 7189-93.

Cited by

  1. The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study vol.12, pp.9, 2017,
  2. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling vol.18, pp.9, 2017,
  3. Dietary Isoflavones and Breast Cancer Risk vol.4, pp.2, 2017,
  4. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools vol.8, pp.10, 2017,
  5. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications pp.00219541, 2017,
  6. Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment vol.23, pp.11, 2018,
  7. Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention vol.9, pp.1664-3224, 2018,
  8. MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women vol.120, pp.1, 2018,
  9. Estrogen alpha receptor antagonists for the treatment of breast cancer: a review vol.12, pp.1, 2018,
  10. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer pp.00219541, 2018,
  11. )-one derivatives orchestrating oxidative stress in human triple-negative breast cancer (MDA-MB-468) pp.03656233, 2018,
  12. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial pp.1432-1041, 2018,
  13. Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress vol.8, pp.1, 2018,
  14. Fibulin-2 is required for basement membrane integrity of mammary epithelium vol.8, pp.1, 2018,
  15. Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap vol.105, pp.11, 2018,
  16. Breast Cancer and Its Relationship with the Microbiota vol.15, pp.8, 2018,
  17. ]pyranones as anticancer agents vol.42, pp.16, 2018,
  18. Association between sleep disorders and the presence of breast cancer metastases in gynecological practices in Germany: a case–control study of 11,412 women vol.171, pp.2, 2018,
  19. The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer? vol.10, pp.6, 2018,
  20. Evaluating dose to thyroid gland in women with breast cancer during radiotherapy with different radiation energies at supraclavicular fossa region pp.1467-1131, 2018,
  21. Diffusionsgewichtete MRT der Brust pp.1432-2102, 2018,
  22. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities vol.8, pp.1, 2018,
  23. Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis vol.11, pp.7, 2018,
  24. Therapeutic effect of simvastatin on DMBA-induced breast cancer in mice pp.07673981, 2018,
  25. gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancer vol.19, pp.9, 2018,
  26. In-vivo Raman spectroscopy: from basics to applications vol.23, pp.07, 2018,
  27. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway vol.18, pp.1, 2018,
  28. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma vol.37, pp.1, 2018,
  29. Fisch. & C.A.Mey extract on the viability and the proliferation of MDA-MB-231 cell line vol.39, pp.1, 2018,
  30. Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review pp.00207136, 2019,
  31. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives vol.38, pp.1, 2019,
  32. Lentivirus-Based Virus-Like Particles Mediate Delivery of Caspase 8 into Breast Cancer Cells and Inhibit Tumor Growth vol.34, pp.1, 2019,